Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5899355 | Diabetes Research and Clinical Practice | 2015 | 6 Pages |
Abstract
The EPO genotype in Chinese patients with type 2 diabetes is associated with anemia and may help to identify those at risk. Further evaluation of its effect on clinical outcomes in prospective studies may be useful to predict the outcomes of erythropoiesis stimulating therapy, and to individualize anemia management.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Terry Ting-Yu Chiou, Jong-Jer Lee, Ming-Chung Wang, Min-Shien Chung, Lin-Lin Pan, Ching-Jung Hsieh, Siang-Ting Huang, Hsueh-Wen Chang, Kuender D. Yang, Chien-Te Lee, Rue-Tsuan Liu,